- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Osteoporosis
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 385KB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 69KB)
Teriparatide – November 2023
Teriparatide: Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled pen; Terrosa®
Last updated
1 March 2024